News
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...
Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...
"Despite this decision of the Court of Justice, the European Commission continues to refuse to make the messages public," ...
US regulators approved Moderna Inc.’s Covid vaccine for children, but for a narrower group than before, continuing Robert F.
Pharmalittle: We’re reading about Regeneron’s patent maneuvers, FDA rejection letters, and lots more
A court battle between Regeneron and Amgen is testing the legal limits of how far drugmakers can go in using patents to ...
Commission president targeted over refusal to release messages related to Covid-19 vaccines and plans for huge defence ...
Challenged over her refusal to release her email exchange with Pfizer CEO, von der Leyen survives after 360 MEPs vote against ...
European Union lawmakers are to hold a confidence vote on the head of the bloc's powerful executive arm, Ursula von der Leyen ...
EU Commission president has come under criticism for refusing to disclose COVID-19 vaccine negotiation documents - Anadolu ...
The motion contained a mix of allegations against Ms von der Leyen, including text messaging privately with the boss of Pfizer during the pandemic.
European Commission President Ursula von der Leyen survived a no-confidence vote over text messages she sent to Pfizer Inc. Chief Executive Officer Albert Bourla during the Covid pandemic.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results